FDA declines to approve Pfizer biosimilar of Roche's cancer drug
(Reuters) - Pfizer Inc said on Monday U.S. regulators declined to approve the company's biosimilar of Roche's blockbuster treatment for breast cancer, Herceptin, and sought additional technical information. (Source: Reuters: Health)
Source: Reuters: Health - April 23, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA declines to approve Pfizer's biosimilar to Roche's cancer drug
(Reuters) - Pfizer Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve the company's biosimilar to Roche's breast cancer drug, Herceptin, and sought additional technical information. (Source: Reuters: Health)
Source: Reuters: Health - April 23, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

How serious is the risk of breast cancer overdiagnosis?
Overdiagnosis of breast cancer -- that is, the detection of cancer on screening...Read more on AuntMinnie.comRelated Reading: Does double reading improve breast cancer screening? Is screening breast MRI being used in the wrong women? Is the mammography debate an example of 'fake science'? Women still value mammography's benefits over 'harms' Do older women benefit from screening mammography? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 23, 2018 Category: Radiology Source Type: news

SSRI Use and Breast Cancer Survival: Cohort Study SSRI Use and Breast Cancer Survival: Cohort Study
Is SSRI use associated with breast cancer mortality?Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Six in 7 women at high risk of breast cancer shun tamoxifen as a preventative measure
(Cancer Research UK) Six in seven women with a family history of breast cancer opt out of taking tamoxifen as a preventative measure, according to a study funded by Cancer Research UK and published in Breast Cancer Research and Treatment today. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 23, 2018 Category: Cancer & Oncology Source Type: news

How to hijack degrading complexes to put cancer cells asleep
(EMBO) Palbociclib is a drug used for the treatment of advanced estrogen-receptor-positive breast cancer. Researchers at the Universities of Dundee and Newcastle and their colleagues investigated the drug's mode of action in more detail and uncovered the proteasome, a cellular degradation machinery vital for the control of cell proliferation, as its yet unknown target. Their discovery could potentially help expand palbociclib-based breast cancer treatments and identify patients that would profit most from this medication. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 23, 2018 Category: Biology Source Type: news

How a False Alarm Affects Future Cancer Screenings
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - April 23, 2018 Category: Cancer & Oncology Source Type: news

Targeted radiotherapy for breast cancer offers good quality of life and fewer side effects
(European Society for Radiotherapy and Oncology (ESTRO)) Quality of life for women treated with a more targeted radiotherapy treatment -- called accelerated partial breast irradiation -- is at least as good as quality of life for women treated with standard radiotherapy, according to research presented at the ESTRO 37 conference and published simultaneously in The Lancet Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 22, 2018 Category: Cancer & Oncology Source Type: news

Science Saturday: Z-Endoxifen emerges as potential breast cancer treatment
Summary Results of a phase I study in women showed that the treatment was safe and reduced tumors. Z-endoxifen, a potent derivative of the drug?tamoxifen, could be a new treatment for the most common form of breast cancer in women with metastatic disease. This finding was reported from a clinical trial conducted by researchers at [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 21, 2018 Category: Databases & Libraries Source Type: news

$2 million grant to push forward cancer research in West Texas
(Texas Tech University Health Sciences Center El Paso) A $2 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT) will allow Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) to create a new lab focusing on breast cancer, pushing forward breast cancer research in West Texas. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 20, 2018 Category: International Medicine & Public Health Source Type: news

NHS WILL fund breast cancer tests that could spare women the stress of chemotherapy
Almost 10,000 women a year are to benefit from NHS breast cancer tests that could spare them the stress of chemotherapy after a U-turn by Nice. (Source: the Mail online | Health)
Source: the Mail online | Health - April 20, 2018 Category: Consumer Health News Source Type: news

Cardiovascular Care of Breast Cancer Survivors Cardiovascular Care of Breast Cancer Survivors
Review the latest strategies for early detection and management of CV disease in patients with a history of breast cancer.Journal of Oncology Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 19, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Economic evaluations of genomic testing may have misleading conclusions
Oncotype DX, a gene profiling test for women with early-stage breast cancer, may not be as effective a tool as commonly thought, according to a new study. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 19, 2018 Category: Universities & Medical Training Source Type: news

Does double reading improve breast cancer screening?
Conclusions?    1) My conclusion is that this proves that double reading adds nothing important to screening - particularly if women are getting yearly mammograms. This should be the stake in the heart of the double reading vampire. Given the criticism of mammography - that it doesn't save many, or any lives, this extra tenth of a percent of diagnosis is even more questionable. Nah, not just questionable, I'd say it is so low that there are probably, within error bars, no lives saved.    Do they say this. No: "Detecting these extra cancers may be associated with detecting important patho...
Source: AuntMinnie.com Headlines - April 19, 2018 Category: Radiology Source Type: news

Study may explain why some triple-negative breast cancers are resistant to chemotherapy
(University of Texas M. D. Anderson Cancer Center) Triple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast cancers. It is a scary diagnosis, and even though chemotherapy can be effective as standard-of-care, many patients become resistant to treatment. A team at The University of Texas MD Anderson led a study which may explain how resistance evolves over time, and potentially which patients could benefit from chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 19, 2018 Category: Cancer & Oncology Source Type: news

Could a Tattoo Someday Spot Your Cancer?
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - April 19, 2018 Category: Cancer & Oncology Source Type: news

Google unveils prototype augmented-reality, AI-powered light microscope system
Google (NSDQ:GOOG) this week presented initial data from a prototype augmented reality microscope platform it’s developing for advanced cancer detection, according to a research blog post from the tech giant. The platform consists of a modified light microscope for real-time image analysis and presents analysis from a machine-learning algorithm directly into the users field of view, Google said. Google said the platform could be retrofitted into existing light microscopes generally used in hospitals and clinics using low-cost, readily-available components without the need for digital versions of the scopes. The ...
Source: Mass Device - April 18, 2018 Category: Medical Devices Authors: Fink Densford Tags: Imaging Research & Development google Source Type: news

OncoMasTR Assay May Help Some Breast Cancer Patients Avoid Chemo
In this video, Dr. Arman Rahman explains how the OncoMasTR protein assay may help women with breast cancer avoid unnecessary chemotherapy. (Source: CancerNetwork)
Source: CancerNetwork - April 18, 2018 Category: Cancer & Oncology Authors: Arman Rahman, MD, MPH, PhD Tags: Conferences/AACR Street Team Breast Cancer News Source Type: news

Olaparib in Breast Cancer: PFS Is Significant but OS Is Not Olaparib in Breast Cancer: PFS Is Significant but OS Is Not
New results from the OlympiAD trial show that overall survival was not significant, but a breast cancer expert says that this will not affect uptake of olaparib for these patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 18, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Researchers identified a protein associated with breast cancer
(UT Southwestern Medical Center) Researchers at UT Southwestern Medical Center have identified a protein that is strongly associated with metastatic breast cancer and that could be a target for future therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 18, 2018 Category: Cancer & Oncology Source Type: news

This bra helps reduce suffering for breast cancer patients undergoing radiation
The medical garment developed at the McGill University Health Centre addresses a little-discussed problem that arises when women with larger breasts go in for radiation treatment. (Source: CBC | Health)
Source: CBC | Health - April 17, 2018 Category: Consumer Health News Tags: News/Canada/Montreal Source Type: news

Novel Study of Endocrine Therapy-Induced Hair Loss Novel Study of Endocrine Therapy-Induced Hair Loss
Breast cancer patients are at risk for alopecia with endocrine therapy, but hair growth can often be restored with topical minoxidil.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

RAD51 Linked With PARP Inhibitor Resistance in BRCA-Mutated Breast Cancer
A biomarker known as RAD51 was found to be correlated with resistance to PARP inhibitor treatment in a study of breast cancer that harbors BRCA mutations. (Source: CancerNetwork)
Source: CancerNetwork - April 17, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news

Xcision Announces Leading Italian Hospital to Acquire GammaPod(TM) Stereotactic Radiotherapy System for Breast Cancer
COLUMBIA, Md., April 17, 2018 -- (Healthcare Sales & Marketing Network) -- Xcision Medical Systems, LLC today announced that Azienda Universitaria Integrata di Udine (ASUIUD) in Italy will acquire the GammaPod™ Stereotactic Radiotherapy System, a new trea... Devices, Oncology Xcision Medical Systems, GammaPod, Stereotactic Radiotherapy System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 17, 2018 Category: Pharmaceuticals Source Type: news

Delay to Formalin Fixation Effect on Breast Cancer Molecules Delay to Formalin Fixation Effect on Breast Cancer Molecules
What effect does delay to formalin fixation have on breast biomarkers such as ER, PR, HER2, Ki-67, and others? Might DFF be a confounding factor in breast biomarker assays?American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 17, 2018 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

For aggressive breast cancer in the brain, researchers clarify immune response
(UNC Lineberger Comprehensive Cancer Center) In a preliminary study presented at the American Association for Cancer Research Annual Meeting 2018 in Chicago, researchers from the UNC Lineberger Comprehensive Cancer Center revealed findings for what kind of immune response the body is staging against triple negative breast cancer that has spread to the brain. They hope they can use these findings to improve patient responses to drugs that work by unleashing the immune system against cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2018 Category: International Medicine & Public Health Source Type: news

These are the top priorities for the nation ’s top cancer doctor
Norman “Ned” Sharpless still remembers one of his favorite patients — a 40-ish woman with breast cancer whose chemotherapy treatment stopped working. During one visit, she told him she knew she wouldn’t be cured but hoped to live just six more years, long enough to see her 11-year-old daughter graduate from high school. “It did […]Related:For advanced lung cancer, immune therapy plus chemo prolongs survivalThis 3-year-old has ‘a sparkle’ in her heart: The world’s smallest mechanical heart valveFDA restricts sale of Essure contraceptive device, requires that women be in...
Source: Washington Post: To Your Health - April 16, 2018 Category: Consumer Health News Source Type: news

These are the top priorities for the nation ’ s top cancer doctor
Norman “Ned”’ Sharpless still remembers one of his favorite patients — a 40-ish woman with breast cancer whose chemotherapy treatment stopped working. During one visit, she told him she knew she wouldn't be cured but hoped to live just six more years, long enough to see her 11-year-old daughter graduate from high school. “It did […]Related:For advanced lung cancer, immune therapy plus chemo prolongs survivalThis 3-year-old has ‘a sparkle’ in her heart: The world’s smallest mechanical heart valveFDA restricts sale of Essure contraceptive device, requires that women be i...
Source: Washington Post: To Your Health - April 16, 2018 Category: Consumer Health News Source Type: news

Can 'Mono' Virus Up Odds for 7 Other Diseases?
The review actually uncovered preliminary links to 94 additional diseases, including breast cancer. (Source: WebMD Health)
Source: WebMD Health - April 16, 2018 Category: Consumer Health News Source Type: news

Breast cancer symptoms - the five signs of a deadly tumour
BREAST cancer symptoms and signs usually include a lump, or thickened area of tissue. These are all of the symptoms to look out for - but is pain a sign of a cancerous tumour? (Source: Daily Express - Health)
Source: Daily Express - Health - April 16, 2018 Category: Consumer Health News Source Type: news

UNC oncologist joins Susan G. Komen advisory ranks
Global breast cancer research nonprofit Susan G. Komen has named Dr. Lisa Carey with the UNC Lineberger Comprehensive Cancer Center to its scientific advisory board. Members of the advisory board aid in guiding the nonprofit’s $956 million research program, according to Komen and UNC. “As part of the Carolina Breast Cancer Study (funded for many years by Komen), [Carey’s] work has taught the field important lessons about triple negative breast cancer, p articularly as it relates to African-American… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 16, 2018 Category: American Health Authors: Jennifer Henderson Source Type: news

MP's assistant claims she 'cured' breast cancer with cannabis oil
Lin Coxon, 69, from Willington, Derbyshire, believes she has beaten the disease, with her latest scan showing 'just small wisps which could be scar tissue'. She first took the oil on June 28. (Source: the Mail online | Health)
Source: the Mail online | Health - April 16, 2018 Category: Consumer Health News Source Type: news

MP's assistant, 69, claims she 'cured' her advanced breast cancer with cannabis oil   
Lin Coxon, 69, from Willington, Derbyshire, believes she has beaten the disease, with her latest scan showing 'just small wisps which could be scar tissue'. She first took the oil on June 28. (Source: the Mail online | Health)
Source: the Mail online | Health - April 16, 2018 Category: Consumer Health News Source Type: news

Study examines accuracy of test for lymph node metastases in women with breast cancer
(Wiley) A new BJS (British Journal of Surgery) study indicates that axillary ultrasound imaging is inferior for detecting axillary node metastasis in patients with breast cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 16, 2018 Category: International Medicine & Public Health Source Type: news

New study discovers cancer-relevant protein shield
(University of Copenhagen The Faculty of Health and Medical Sciences) Researchers from the Novo Nordisk Foundation Center for Protein Research have uncovered a new protein shield that aids in repairing damaged DNA in cells and affects resistance to drugs used for breast cancer treatment. The new study has just been published in the internationally acclaimed scientific journal Cell. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 16, 2018 Category: Cancer & Oncology Source Type: news

COUNTERPOINT: LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients
Though LHRH agonists may be the preferred method of ovarian function suppression, ovarian ablation is a viable option for select premenopausal breast cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - April 15, 2018 Category: Cancer & Oncology Authors: Ann H. Partridge, MD, MPH Philip D. Poorvu, MD Tags: Breast Cancer Oncology Journal Source Type: news

POINT: LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients
Reversible ovarian function suppression using LHRH agonists is the preferred first treatment for most premenopausal breast cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - April 15, 2018 Category: Cancer & Oncology Authors: Gini F. Fleming, MD Padma Rajagopal, MD Tags: Breast Cancer Oncology Journal Source Type: news

Medical News Today: Breast cancer: Common drugs may halt post-surgery relapse
Some people develop early metastases following breast cancer surgery. New research sheds light on why that happens, and how it might be prevented. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 15, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Busting Myths Surrounding Cancer and Genetic Testing
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - April 14, 2018 Category: Cancer & Oncology Source Type: news

Pregnant woman, 29, diagnosed with terminal cancer after scan 17 weeks into her first pregnancy
Laura King, a nursery director from Surrey, beat breast cancer in 2017. After the all-clear, she and her husband decided to start a family. Weeks later, she was diagnosed with secondary bone cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - April 13, 2018 Category: Consumer Health News Source Type: news

Alopecia caused by hormone therapy in breast cancer
A study, published inJAMA Dermatology, reports that endocrine therapy-induced alopecia in breast cancer patients is mechanistically similar to androgenetic alopecia.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 13, 2018 Category: Endocrinology Source Type: news

Multiparametric MRI shines for suspected breast cancer
Dynamic contrast-enhanced MRI and diffusion-weighted imaging each have advantages...Read more on AuntMinnie.comRelated Reading: Is screening breast MRI being used in the wrong women? Leave no invasive breast cancer behind by using MRI Breast MRI technique helps cancer detection without contrast Multiparametric MRI can help avoid renal mass biopsies BMJ: Multiparametric MRI has role in prostate screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 13, 2018 Category: Radiology Source Type: news

DBT improves breast cancer screening in young women
Adding digital breast tomosynthesis (DBT) to digital mammography improves breast...Read more on AuntMinnie.comRelated Reading: FDA authorizes ACR to accredit DBT devices DBT know-how boosts FFDM recall, cancer detection rates Deep learning may produce sharp reductions in DBT dose DBT screening shows greatest benefit for younger women DBT plus 2D mammography improves radiologist performance (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 13, 2018 Category: Radiology Source Type: news

Chemotherapy-Associated Neuropathy in Early Breast Cancer Chemotherapy-Associated Neuropathy in Early Breast Cancer
Neuropathic symptoms may persist in over 80% of patients receiving adjuvant chemotherapy for early breast cancer.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 13, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Quality of Life Predicts Mortality in Older Breast Cancer Patients
Compared to model with only traditional prognostic variables, one with HRQOL measures performs better (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 13, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Geriatrics, Journal, Source Type: news

Video: Mammogram for breast cancer & mdash; What to expect
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - April 13, 2018 Category: Consumer Health News Source Type: news

HER2+ Breast Cancer Subtypes Resistant to TKIs Through Differing Mechanisms
Laboratory studies suggest that mechanisms of resistance to tyrosine kinase inhibitor therapy differ between the specific subtypes of HER2-positive breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 12, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer HER2-Positive Breast Cancer News Source Type: news

Quality of Life Predicts Mortality in Older Breast Cancer Patients
THURSDAY, April 12, 2018 -- For older women with early-stage breast cancer, measures of health-related quality of life (HRQOL) predict 10-year mortality independently of traditional breast cancer prognostic variables, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2018 Category: Pharmaceuticals Source Type: news

Endocrine Therapy - Induced Alopecia Seen in Breast Cancer
92 percent had grade 1 severity alopecia with endocrine tx; pattern similar to androgenetic alopecia (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 12, 2018 Category: Cancer & Oncology Tags: Dermatology, Gynecology, Oncology, Pharmacy, Journal, Source Type: news

WATCH: New study in mice explores how breast cancer surgery may trigger cancer spread
Dr. Jennifer Ashton discusses what to know about a new study that suggests the wound healing following surgery in mice may trigger the spread of cancer. (Source: ABC News: Health)
Source: ABC News: Health - April 12, 2018 Category: Consumer Health News Tags: GMA Source Type: news